Join Amgen's dynamic team as an Associate Software Engineer and take part in transforming biological sciences into pioneering therapies. This role offers the chance to design, develop, and deploy complex software alongside leading professionals in the field. As an integral member of the team, you'll contribute to creating scalable and maintainable solutions in a globally recognized biotechnology firm.
Proficiency in React, Redux, JavaScript, TypeScript, SQL, Microservices, AWS/Azure, and more. Experience with Agile methodologies and DevOps practices is preferred. Familiarity with API and End-to-End testing is beneficial.
This position welcomes graduates from recent batches, specifically 2023 and 2024
As a leader in biotechnology, Amgen prioritizes not just innovation but the welfare of its employees. The company offers competitive salaries and a comprehensive rewards program aligned with industry standards, promoting personal and professional growth. Be a part of their mission to improve lives—begin a career at Amgen today.
Amgen Inc. is a leading multinational biotechnology company headquartered in Thousand Oaks, California, USA. Founded in 1980, Amgen is dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Its mission is to serve patients by transforming scientific discoveries into medicines that improve lives, with a focus on areas such as oncology, cardiovascular disease, neuroscience, and inflammation. The company is recognized for pioneering biologics and leveraging advanced genetic research to address serious illnesses.
With over 25,000 employees worldwide, Amgen holds a strong position in the global biotech market, consistently ranking among the largest biotechnology firms by revenue. It has a diverse portfolio of approved medicines, including well-known biologics like Enbrel, Neulasta, and Prolia, as well as a robust pipeline of investigational therapies. Recently, Amgen has made headlines for strategic acquisitions, such as its purchase of Horizon Therapeutics in 2023, expanding its rare disease portfolio, and for advancing cutting-edge research in biosimilars and precision medicine. The company is also committed to sustainability and corporate responsibility, aiming to reduce its environmental footprint while maintaining high standards of scientific excellence.
Websiteamgen.com
